Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease

被引：0
|
作者：
Audrey Benyamine
Xavier Heim
Noémie Resseguier
Daniel Bertin
Carine Gomez
Mikaël Ebbo
Jean-Robert Harlé
Gilles Kaplanski
Pascal Rossi
Nathalie Bardin
Brigitte Granel
机构：
[1] APHM,CHU Nord, Internal Medicine Department, North hospital of Marseilles
[2] Aix Marseille Univ,CHU Conception, Immunology Laboratory
[3] INSERM,CHU Timone, Epidemiology and Health Economics Unit
[4] INRA,CHU Nord, Pneumology Department
[5] C2VN,CHU Timone, Internal Medicine Department
[6] APHM,CHU Conception, Internal Medicine Department
[7] APHM,undefined
[8] Aix-Marseille University (AMU),undefined
[9] Faculty of Medicine,undefined
[10] APHM,undefined
[11] APHM,undefined
[12] APHM,undefined
来源：
Rheumatology International | 2018年 / 38卷
关键词：
Krebs von den Lungen-6; Systemic sclerosis; Lung fibrosis; Disease severity; Anti-topoisomerase 1 antibody (Scl70);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：813 / 819
页数：6
相关论文
共 50 条
  • [21] Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
    Shirai, Yuichiro
    Fukue, Ryosuke
    Kaneko, Yuko
    Kuwana, Masataka
    DIAGNOSTICS, 2021, 11 (11)
  • [22] Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease
    d'Alessandro, Miriana
    Conticini, Edoardo
    Bergantini, Laura
    Mazzei, Maria Antonietta
    Bellisai, Francesca
    Selvi, Enrico
    Cameli, Paolo
    Frediani, Bruno
    Bargagli, Elena
    TISSUE & CELL, 2024, 90
  • [23] Serum Krebs Von Den Lungen-6 Level in the Prognosis, Disease Progression, and Treatment of Mycobacterium Avium Complex Lung Disease
    Asakura, T.
    Kimizuka, Y.
    Nishimura, T.
    Suzuki, S.
    Masugi, Y.
    Ishii, M.
    Hasegawa, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019
    Chen, Hao
    Qin, Rundong
    Huang, Zhifeng
    Luo, Wenting
    Zheng, Peiyan
    Huang, Huimin
    Hu, Haisheng
    Wang, Hui
    Sun, Baoqing
    CYTOKINE, 2021, 148
  • [25] Serum Krebs Von Den Lungen-6 Is a Useful Biomarker for Assessing Activity of Myositis-Associated Interstitial Lung Disease
    Takanashi, Satoshi
    Nishina, Naoshi
    Nakazawa, Maho
    Kaneko, Yuko
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [26] Association of Serum Krebs von den Lungen-6 (KL-6) Levels and Disease Severity in Patients Hospitalized with COVID-19
    Evlice, Oguz
    Bektas, Murat
    Kar, Fatih
    Marim, Feride
    Kaya, Ilknur
    Yorukoglu, Kerem
    Ak, Oznur
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2023, 5 (04): : 292 - 299
  • [27] Interleukin-6 and krebs von den lungen-6 in lymphangioleiomyomatosis patients
    Perea, Beatrice
    D'Alessandro, Miriana
    Bergantini, Laura
    Gangi, Sara
    Zilio, Benedetta
    Cameli, Paolo
    Bargagli, Elena
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [28] Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis
    Shigemura, Masahiko
    Nasuhara, Yasuyuki
    Konno, Satoshi
    Shimizu, Chikara
    Matsuno, Kazuhiko
    Yamguchi, Etsuro
    Nishimura, Masaharu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [29] Serum Krebs von den Lungen-6 levels in psoriatic patients under treatment with biologics
    Iwata, Hiroaki
    Haga, Naoya
    Sugai, Tatsuro
    Fujita, Yasuyuki
    JOURNAL OF DERMATOLOGY, 2021, 48 (03): : 376 - 379
  • [30] Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes
    D'Alessandro, Miriana
    Cameli, Paolo
    Bergantini, Laura
    Franchi, Federico
    Scolletta, Sabino
    Bargagli, Elena
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 657 - 657
12345